Elicio Therapeutics
Elicio Therapeutics is an HPV-induced cancer treatments founded in 2011 by Satish Jindal.
6
Funding Rounds
$224.4m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Sa**** Ji**** |
|
- | |
| Da***** Ir**** |
|
- |
| Name | Phone | Social networks | |
|---|---|---|---|
| Da***** Ir**** |
|
- | |
| Ju**** Ad*** | - | - | |
| Ro**** Co****** | - | - | |
| Da**** Ge***** | - | - | - |
| Ca*** As** | - | - | - |
| Of** Go*** |
|
- | - |
| Da**** Ka***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Elicio Therapeutics has raised a total of $153m in funding over 6 rounds.
Key Insights:
- Elicio Therapeutics Funding Round, May 2022: $50m
- Elicio Therapeutics Series B round, February 2021: $73m
- Elicio Therapeutics , March 2019: $30m
- Elicio Therapeutics, Inc. funding round, July 2020: $30m
- Elicio Therapeutics funding round, October 2019: $33m
- Elicio Therapeutics, Inc. funding round, March 2020: $8.41m
Elicio Therapeutics Funding Round, May 2022
$50m
Elicio Therapeutics Series B round, February 2021
$73m
Elicio Therapeutics , March 2019
$30m
Elicio Therapeutics, Inc. funding round, July 2020
$30m
Elicio Therapeutics funding round, October 2019
$33m
Elicio Therapeutics, Inc. funding round, March 2020
$8.41m
Industries
Elicio Therapeutics is active in the following industries: